成人特应性皮炎疾病严重程度与皮肤微生物组及丝聚蛋白基因突变的关联
丹麦一家三级转诊中心2015年1月至6月开展的观察性病例对照研究,纳入45名成人健康对照和56名成人特应性皮炎患者,采用16S核糖体RNA测序分析皮肤与鼻腔微生物组。患者非皮损、皮损及鼻腔微生物α多样性与健康对照相比均降低,且患者皮损与非皮损α多样性与疾病严重程度呈负相关,非皮损微生物组组成与丝聚蛋白基因突变相关。
要点
- 特应性皮炎患者非皮损、皮损及鼻腔微生物α多样性均低于健康对照。
- 患者皮损与非皮损微生物α多样性与疾病严重程度呈负相关。
- 患者非皮损皮肤微生物组组成与丝聚蛋白基因突变相关。
核心结论
- 特应性皮炎患者非皮损皮肤、皮损皮肤及鼻腔微生物组组成改变,提示特应性皮炎具有全局性影响。
- 特应性皮炎非皮损皮肤微生物组组成与丝聚蛋白基因突变相关,提示皮肤微生物组与宿主遗传之间可能存在关联。
研究设计与样本
- 观察性病例对照研究,纳入45名成人健康对照和56名成人特应性皮炎患者。
- 研究于2015年1月至2015年6月在丹麦Bispebjerg医院皮肤科一家三级转诊中心开展。
- 从患者皮损皮肤、非皮损皮肤及鼻前庭和健康对照非皮损皮肤及鼻前庭采集细菌拭子。
- 提取细菌DNA,扩增V3-V4 16S rDNA区域,样本于2015年9月至2016年9月在Statens Serum Institut分析。
- 使用R统计软件(版本3.3.1,R Foundation Inc)进行微生物组生物信息学分析。
主要发现
- 非皮损皮肤微生物α多样性在患者中低于健康对照(效应量0.710;95%CI 0.27-1.15;P=.002)。
- 皮损皮肤微生物α多样性在患者中低于健康对照(效应量0.728;95%CI 0.35-1.33;P=.001)。
- 鼻腔微生物α多样性在患者中低于健康对照(效应量1.111;95%CI 0.48-0.94;P<.001)。
- 患者皮损皮肤α多样性与疾病严重程度呈负相关(效应量0.530;95%CI 0.23-1.64;P=.02)。
- 患者非皮损皮肤α多样性与疾病严重程度呈负相关(效应量0.451;95%CI 0.04-2.44;P=.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Skin microbiome correlates with disease severity for lesional and nonlesional skin, indicating a global influence of atopic dermatitis (AD). A relation between skin microbiome and filaggrin gene (FLG) mutations proposes a possible association between skin microbiome and host genetics. OBJECTIVES: To assess skin and nasal microbiome diversity and composition in patients with AD and compare with healthy controls, and to investigate the microbiome in relation to disease severity and FLG mutations in patients with AD. DESIGN, SETTING, AND PARTICIPANTS: An observational case-control study of 45 adult healthy controls and 56 adult patients with AD was carried out from January 2015 to June 2015 in a tertiary referral center, Department of Dermatology, Bispebjerg Hospital, Denmark. EXPOSURES: Bacterial swabs were taken from patients with AD (lesional skin, nonlesional skin, and anterior nares) and from healthy controls (nonlesional skin and anterior nares). Eczema severity was assessed and FLG mutations noted. Bacterial DNA was extracted from swabs, and V3-V4 16S rDNA regions amplified with PCR. Samples were analyzed at Statens Serum Institut September 2015 to September 2016. Bioinformatics analyses of the microbiome were analyzed using R statistical software (version 3.3.1, R Foundation Inc). MAIN OUTCOMES AND MEASURES: Skin microbiomes were investigated using next-generation sequencing targeting 16S ribosomal RNA. RESULTS: Microbiome alpha diversity was lower in patients with AD compared with healthy controls in nonlesional skin (effect size, 0.710; 95% CI, 0.27-1.15; P = .002), lesional skin (effect size, 0.728; 95% CI, 0.35-1.33; P = .001), and nose (effect size, 1.111; 95% CI, 0.48-0.94; P < .001). Alpha diversity was inversely correlated with disease severity for lesional (effect size, 0.530; 95% CI, 0.23-1.64; P = .02) and nonlesional skin (effect size, 0.451; 95% CI, 0.04-2.44; P = .04) in patients with AD. Microbiome composition in AD nonlesional skin was linked to FLG mutations. CONCLUSIONS AND RELEVANCE: An altered microbiome composition in patients with AD in nonlesional skin, lesional skin, as well as nose, suggests a global influence of AD. Microbiome composition in AD nonlesional skin is associated with FLG mutations, proposing a possible association between the skin microbiome and host genetics.
引用
- Clausen ML, Agner T, Lilje B, et al. Association of Disease Severity With Skin Microbiome and Filaggrin Gene Mutations in Adult Atopic Dermatitis. JAMA Dermatol. 2018. PMID: 29344612. doi:10.1001/jamadermatol.2017.5440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。